Avon's $51M Talc Verdict Upheld in Landmark Cancer Case

LOS ANGELES, CA – February 11, 2026 – A California appeals court has affirmed a staggering $51 million verdict against cosmetics giant Avon, cementing a landmark decision that holds the company responsible for a woman’s death from asbestos-contaminated talcum powder. The ruling marks a significant victory for victims and their families in the sprawling, multi-billion dollar litigation targeting the personal care industry.

The decision by the California 2nd District Court of Appeals on Wednesday rejected Avon's challenges and upheld the original 2022 jury award in full. The case was brought by Rita-Ann Chapman and her husband, Gary, who argued that decades of using Avon's talc-based face and body powders led to her developing mesothelioma, a rare and aggressive cancer caused exclusively by asbestos exposure. Mrs. Chapman passed away in March 2025, just over two years after the initial verdict was delivered.

“Companies cannot ignore science, disregard their own internal warnings and put profits over people’s health without being held accountable,” said Jessica Dean of Dean Omar Branham Shirley, the law firm representing the Chapman family. “The evidence at trial showed that for decades Avon knew its talc was contaminated. While this decision cannot erase the pain the Chapman family has endured, it affirms that corporate misconduct will not go unanswered.”

The Human Cost of a Household Product

For millions, Avon products were a staple of American households, sold door-to-door by the iconic “Avon Ladies.” For Rita-Ann Chapman, they were a part of her daily routine from childhood. Her attorneys detailed how she began using Avon's powders at the age of eight and continued to do so for most of her life, trusting the brand's wholesome image. That trust was shattered when she was diagnosed with mesothelioma, a terminal illness that attacks the delicate lining of the body's organs.

The lawsuit contended that the talc used in Avon's products was tainted with asbestos, a known carcinogen. Talc, a soft mineral, is often mined from deposits that are geologically intermingled with asbestos, making contamination a persistent risk without rigorous testing and sourcing protocols. The jury in the original trial found Avon 90% responsible for Mrs. Chapman's cancer, awarding her family $40.8 million in actual damages and an additional $11.3 million in punitive damages intended to punish the company for its conduct.

A Pattern of Alleged Deception

The Chapman verdict is not an isolated incident but rather a critical data point in a long history of litigation against Avon. Court documents and evidence from multiple trials suggest the company was aware of potential asbestos contamination in its talc supplies as far back as the 1970s. Despite this internal knowledge, plaintiffs have consistently argued that Avon never placed warnings on its products or informed the public of the potential risk.

Facing mounting legal pressure, Avon announced it would stop using talc in its U.S. product lines in 2020, transitioning to cornstarch-based alternatives. However, the company continues to sell talc-based products in many international markets. The financial toll of this legacy has been immense. In August 2024, Avon’s U.S.-based holding company, Avon Products, Inc., filed for Chapter 11 bankruptcy to manage what it termed “legacy talc liabilities” and over $300 million in debt. The bankruptcy plan, approved a year later, established an asbestos trust fund to compensate victims, a common strategy for companies facing mass tort claims related to asbestos.

This legal strategy separates the U.S. entity handling liabilities from the global operations now owned by Natura &Co, which acquired Avon in 2020. The North American Avon brand itself is owned by a separate company, LG Household & Health Care Ltd., and is not involved in the bankruptcy proceedings.

An Industry Under Fire

The legal battles faced by Avon are a microcosm of a much larger crisis confronting the cosmetics and personal care industry. The primary target of talc litigation has been Johnson & Johnson (J&J), which faces an astonishing 90,000 lawsuits from individuals who claim its iconic Baby Powder and other talc products caused ovarian cancer and mesothelioma.

The scale of the verdicts against J&J has been astronomical. In December 2025, a Baltimore jury awarded $1.5 billion to a single plaintiff who developed mesothelioma. Just months earlier, in October 2025, a Los Angeles jury ordered the company to pay $966 million to the family of another victim. J&J’s attempts to resolve the litigation through complex bankruptcy maneuvers have been repeatedly rejected by courts, leaving the healthcare giant exposed to further jury awards.

This wave of litigation has fundamentally altered the industry landscape. Consumer awareness has skyrocketed, and public health advocates are demanding greater transparency and stricter regulation. However, the path forward remains contentious. In a move that stunned consumer safety groups, the U.S. Food and Drug Administration (FDA) withdrew a proposed rule in November 2025 that would have mandated standardized asbestos testing for talc-based cosmetics. Critics argue this decision leaves a dangerous regulatory vacuum, allowing companies to self-police their supply chains.

This stands in stark contrast to the approach in Europe, where the European Union is moving to ban talc from all cosmetics by 2027. This growing regulatory divergence highlights a global split on how to handle the potential dangers lurking in makeup bags and medicine cabinets. As American courts continue to deliver nine- and ten-figure verdicts, the pressure builds on both regulators and corporations to provide definitive answers about the safety of products used by millions every day.